AAV9-IDS gene therapy (Nationwide Children's Hospital)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV9-IDS gene therapy (Nationwide Children's Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionIduronate-2-sulfatase gene transference
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNationwide Children'S Hospital
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidosis II

Other Information

ATC CodeN/A
Related LinksN/A